Insight

Al Kenz Pharmaceuticals was proud to partner with the American Spine Center for the Regenerative Medicine Middle East Congress 2026, held in Dubai from 23 to 25 October.

The congress brought together healthcare professionals, researchers and industry leaders to exchange knowledge on developments in regenerative medicine. The programme included a two-day scientific congress followed by a specialised workshop hosted by the American Spine Center.

Throughout the event, the Al Kenz team showcased Mukosat®, our injectable chondroitin sulphate solution developed for the symptomatic management of osteoarthritis.

Mukosat® contains chondroitin sulphate 200 mg and is administered by intramuscular injection. It is intended to help manage osteoarthritis symptoms, including joint pain and stiffness, while supporting cartilage matrix maintenance.

Our partnership with the American Spine Center reflects a shared commitment to scientific education, meaningful collaboration and the advancement of joint health and patient care across the region.

We thank the American Spine Center, the congress organisers, speakers and healthcare professionals who contributed to the success of the event.